# Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

> **NCT05064839** · PHASE3 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 553 (actual)

## Conditions studied

- Transthyretin Cardiac Amyloidosis

## Interventions

- **PROCEDURE:** Bony scintigraphy

## Key facts

- **NCT ID:** NCT05064839
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-06
- **Primary completion:** 2023-08-18
- **Final completion:** 2023-08-18
- **Target enrollment:** 553 (ACTUAL)
- **Last updated:** 2023-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064839, "Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)". Retrieved via AI Analytics 2026-09-20 from https://api.ai-analytics.org/clinical/NCT05064839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*